Stay updated on Talazoparib in DNA Repair Defects Clinical Trial
Sign up to get notified when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.

Latest updates to the Talazoparib in DNA Repair Defects Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s footer revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a maintenance/version change to the ClinicalTrials.gov site UI rather than any study information.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded a new Lancet Oncology TALAPRO-1 publication citation (de Bono et al., 2021) with an erratum in 2022 and updated the revision to v3.5.2. Removed the older TALAPRO-1 citation with revision v3.5.0.SummaryDifference0.0%

- Check38 days agoChange DetectedLocation entry updated from Padua, Italy, 35128 to Padova, Italy, 35128. The site name now uses the local Italian spelling.SummaryDifference0.0%

- Check46 days agoChange DetectedRemoved related topics: Prostate cancer and MedlinePlus Genetics from the related topics section.SummaryDifference0.1%

- Check53 days agoChange DetectedUpdated the Italy location listing from Napoli, Italy (80131) to Naples, Italy (80131) (Naples, 80131 added; Napoli, 80131 removed). Added related topics: Prostate cancer and MedlinePlus Genetics.SummaryDifference0.1%

- Check67 days agoChange DetectedUpdated page revision from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Talazoparib in DNA Repair Defects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.